News HLB Co., Ltd.

Equities

A028300

KR7028300002

End-of-day quote Korea S.E. Other stock markets 03:30:00 28/06/2024 am IST			5-day change	1st Jan Change
58,500 ^KRW	-8.45%		-9.02%	+15.38%

14/05	HLB Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
01/04	HLB Therapeutics Co.,Ltd. announced that it has received KRW 29.99999658 billion in funding from HLB Co., Ltd.	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

HLB Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05	CI
HLB Therapeutics Co.,Ltd. announced that it has received KRW 29.99999658 billion in funding from HLB Co., Ltd.	01/04	CI
HLB Life Science to Raise 148.5 Billion Won via Shares Issuance; Shares Decline 8%	22/03	MT
HLB Therapeutics Co.,Ltd. announced that it expects to receive KRW 29.99999658 billion in funding from HLB Co., Ltd. and other investors	22/03	CI
HLB Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	21/03	CI
HLB Co., Ltd. announced that it has received KRW 60 billion in funding from a group of investors	08/03	CI
HLB Co., Ltd. announced that it expects to receive KRW 60 billion in funding from a group of investors	04/03	CI
Bank of Canada Holds Rates Steady; ECB Expected -2-	25/01	DJ
South Korean Shares Marginally Decline for Second Day on Profit-Booking	22/12	MT
HLB Shareholders Endorse Transition to Main Bourse from KOSDAQ	22/12	MT
BPH Energy Appoints HLB Mann Judd as Auditor; Shares Plunge 10%	22/11	MT
Century Sunshine Group’s Auditor Resigns; Successor Named	17/11	MT
Rare Earth Magnesium’s Auditor Steps Down; Successor Appointed	17/11	MT
Jinhai International Gets New Auditor	14/11	MT
HLB Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
HLB, Hong Leong Islamic Bank, Cagamas Conclude MYR300 Million Green Assests Deal	04/23/04	MT
Spenda Halts Trade Pending Court Nod for Auditor Appointment	04/23/04	MT
5E Resources Appoints New Auditors	01/23/01	MT
Elevar Therapeutics, Inc. announced that it has received KRW 58.174676146 billion in funding from HLB Co., Ltd.	11/23/11	CI
Elevar Therapeutics, Inc. announced that it expects to receive KRW 58.174676146 billion in funding from HLB Co., Ltd.	09/23/09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News HLB Co., Ltd.

Equities

A028300

KR7028300002

Summary

Filters